...
首页> 外文期刊>International Journal of Preventive Medicine >Association of Factor V Leiden and Prothrombin G20210A Polymorphisms in Women with Recurrent Pregnancy Loss in Isfahan Province, Iran
【24h】

Association of Factor V Leiden and Prothrombin G20210A Polymorphisms in Women with Recurrent Pregnancy Loss in Isfahan Province, Iran

机译:伊朗伊斯法罕省妇女复发性流产的因素V莱顿和凝血酶原G20210A多态性的关联

获取原文

摘要

Background: Maternal thrombophilia has been identified as a risk factor for recurrent pregnancy loss (RPL). The aim of this study was to investigate the association between prothrombin G20210A and factor V Leiden (FVL) polymorphisms in women with RPL and a control group of parous women in Isfahan province of Iran. Methods: We studied 250 women with idiopathic RPL and 116 control cases. Prothrombin and FVL different genotypes were determined using polymerase chain reaction and reverse hybridization technique. Results: The frequencies of heterozygous mutation prothrombin G20210A were 6% and 0.9%, respectively ( P = 0.025), in cases compared to the control group. The frequencies of homozygous mutation prothrombin G20210A were 0.4% and 0%, respectively, in cases compared to controls ( P = 0.02). The prothrombin mutation was significantly higher in cases compared to the control group (odds ratio 8.81; 95% confidence interval: 1.16–66.62). There was no significant difference between the FVL mutation and pregnancy loss. Conclusions: The results indicated a significant higher frequency of prothrombin G20210A in women with RPL in comparison with controls. Our data suggest that the prothrombin G20210A mutation, but not the FVL mutation, may be an unrecognized cause of RPL in our population.
机译:背景:母亲的血栓形成倾向已被确定为反复妊娠流产(RPL)的危险因素。这项研究的目的是调查伊朗伊斯法罕省有RPL的女性和对照组妇女的凝血酶原G20210A与凝血因子V Leiden(FVL)多态性之间的关联。方法:我们研究了250例特发性RPL妇女和116例对照病例。使用聚合酶链反应和反向杂交技术确定凝血酶原和FVL的不同基因型。结果:与对照组相比,杂合突变凝血酶原G20210A的发生率分别为6%和0.9%(P = 0.025)。与对照组相比,纯合子突变凝血酶原G20210A的频率分别为0.4%和0%(P = 0.02)。与对照组相比,凝血酶原突变明显更高(赔率8.81; 95%置信区间:1.16-66.62)。 FVL突变和流产之间没有显着差异。结论:结果表明,与对照组相比,RPL妇女的凝血酶原G20210A的发生频率显着更高。我们的数据表明,凝血酶原G20210A突变而不是FVL突变可能是我们人群中RPL的未知原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号